Advertisement VLife Sciences Technologies Enters Into Agreement With NCBS - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

VLife Sciences Technologies Enters Into Agreement With NCBS

VLife Sciences Technologies (VLife), an India-based provider of technologies for computer aided drug and molecular discovery, has entered into a contract with Bengaluru-based National Centre for Biological Sciences (NCBS), for developing a specialised modeling and simulation technology in the area of protein-protein interactions that would aid research in computational molecular discovery.

The project is undertaken jointly by NCBS, Stanford University and Technical University of Denmark.

VLife Sciences Technologies said that the project involves studying coiled coil interactions in proteins which will provide opportunity to encounter and study hitherto uncharacterised myosins, key players in the dynamic organisation of cellular components.

Supreet Deshpande, director of VLife Sciences Technologies, said: “We are very pleased to be part of this collaboration involving highly reputed research institutes which rank among the best in the world and for the opportunity to work with some of the leading scientific minds. We are confident that this collaboration will result in an easy to use computational software solution which provides deeper insights into the complex domain of protein-protein interactions.”